Michael McFadden - Alpha Cognition CEO Director
| ACOGFDelisted Stock | USD 6.41 0.06 0.94% |
Insider
Michael McFadden is CEO Director of Alpha Cognition
| Age | 56 |
| Web | https://www.alphacognition.com |
Alpha Cognition Management Efficiency
The company has return on total asset (ROA) of (1.6088) % which means that it has lost $1.6088 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (6.9694) %, meaning that it generated substantial loss on money invested by shareholders. Alpha Cognition's management efficiency ratios could be used to measure how well Alpha Cognition manages its routine affairs as well as how well it operates its assets and liabilities.Alpha Cognition has accumulated 1.14 M in total debt with debt to equity ratio (D/E) of 0.27, which may suggest the company is not taking enough advantage from borrowing. Alpha Cognition has a current ratio of 3.02, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Alpha Cognition until it has trouble settling it off, either with new capital or with free cash flow. So, Alpha Cognition's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Alpha Cognition sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Alpha to invest in growth at high rates of return. When we think about Alpha Cognition's use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | INSIDER Age | ||
| Mark Meier | Fennec Pharmaceuticals | N/A | |
| John MBA | Ascletis Pharma | N/A | |
| Ming CPA | Ascletis Pharma | N/A | |
| Gaelle Stadtler | Transgene SA | 40 | |
| Hedi Brahim | Transgene SA | 42 | |
| Hejingdao Wu | Ascletis Pharma | 49 | |
| Anne McKay | Fennec Pharmaceuticals | 70 | |
| Mark Gowland | Fennec Pharmaceuticals | N/A | |
| Gustavo Scaffa | ImmuCell | N/A | |
| Jinzi Wu | Ascletis Pharma | 60 | |
| Handan He | Ascletis Pharma | 61 | |
| Yuemei Yan | Ascletis Pharma | 53 | |
| George Hill | Ascletis Pharma | 72 | |
| Philippe Slos | Transgene SA | N/A | |
| Kristjan Gudmundsson | Ascletis Pharma | 55 | |
| Maud MD | Transgene SA | 69 | |
| LLM JD | Transgene SA | 53 | |
| Steven RPh | Transgene SA | 61 | |
| Lucie Larguier | Transgene SA | N/A | |
| Alexander MS | Fennec Pharmaceuticals | N/A | |
Management Performance
| Return On Equity | -6.97 | |||
| Return On Asset | -1.61 |
Alpha Cognition Leadership Team
Elected by the shareholders, the Alpha Cognition's board of directors comprises two types of representatives: Alpha Cognition inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Alpha. The board's role is to monitor Alpha Cognition's management team and ensure that shareholders' interests are well served. Alpha Cognition's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Alpha Cognition's outside directors are responsible for providing unbiased perspectives on the board's policies.
| LLB BA, Special Founder | ||
| Colleen Johns, VP Devel | ||
| Lauren MBA, Chief Officer | ||
| Denis Kay, Chief Officer | ||
| Donald BA, Chief Officer | ||
| Michael McFadden, CEO Director | ||
| MBA MD, Chief Officer |
Alpha Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right otc stock is not an easy task. Is Alpha Cognition a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -6.97 | |||
| Return On Asset | -1.61 | |||
| Current Valuation | 14.92 M | |||
| Shares Outstanding | 61.02 M | |||
| Shares Owned By Insiders | 29.84 % | |||
| Shares Owned By Institutions | 0.73 % | |||
| Price To Book | 9.90 X | |||
| Gross Profit | (37.5 K) | |||
| EBITDA | (18.93 M) | |||
| Net Income | (19.55 M) |
Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in price. Note that the Alpha Cognition information on this page should be used as a complementary analysis to other Alpha Cognition's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Other Consideration for investing in Alpha OTC Stock
If you are still planning to invest in Alpha Cognition check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Alpha Cognition's history and understand the potential risks before investing.
| CEOs Directory Screen CEOs from public companies around the world | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |